Clinical Trials Browser

Phase 2 × Neurofibrosarcoma × pembrolizumab × Clear all

NCT02691026 2021-06-23

A Study of Pembrolizumab in Patients With Malignant Peripheral Nerve Sheath Tumor (MPNST), Not Eligible for Curative Surgery

Phase 2 Terminated

Neurofibrosarcoma